Lens and associatable flow cell

Optical waveguides – Optical waveguide sensor

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C385S014000, C385S129000, C385S130000, C385S131000, C385S033000, C422S082050, C422S082110, C436S518000, C356S317000

Reexamination Certificate

active

06611634

ABSTRACT:

BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates generally to components of a diagnostic apparatus and, more particularly, to an improved biosensor having a lens (“waveguide”) and associated flow cell.
2. State of the Art
International Application No. PCT/US94/05567 (International Publication No. 94/27137, published Nov. 24, 1994) to the University of Utah Research Foundation discloses an apparatus for multi-analyte homogeneous fluoroimmunoassays. In one embodiment, the application discloses an apparatus which uses a biosensor having a planar waveguide sandwiched, with an associated gasket, between two plates (FIGS. 3A-3C of Internat'l Publ. No. 94/27137). The inner edges of the gasket serve as walls for a reaction reservoir or well. Fluorescence-emitting tracer molecules are bound to the waveguide surface and are excited by an evanescent field penetrating into the adjacent solution from a light beam propagated within the waveguide, the beam being introduced at, for example, a front end of the waveguide. In the reaction reservoir, a liquid (e.g., serum or blood) is introduced and is allowed to admix with capture molecules associated with the waveguide surface (e.g., by “coating chemistry” as disclosed on pages 32 to 33 of the international application). The emitted fluorescence is then directly collected from the zone of evanescent penetration. In one particular embodiment, the biosensor has transparent walls which define the reservoirs (e.g., FIGS. 11A-C of Internatl. Publn. No. 94/27137). The application also discloses integrally formed or molded biosensors (e.g., FIGS. 12A, 12B & 13 of Internatl. Publn. No. 94/27137).
Unfortunately, the waveguide portion of integrally formed or molded biosensors may exhibit deformation upon fabrication, or warping during storage or temperature changes. Also, gaskets may not reliably seal or are not always sufficiently inert to reactants and, thus, may interfere with the desired analysis.
It would be desirable to have a biosensor having reservoirs with inert walls, the walls being readily detachable from the waveguide so that one waveguide could be readily exchanged for another.
BRIEF SUMMARY OF THE INVENTION
The invention includes a biosensor with a reservoir or reservoirs, the biosensor including a waveguide placed (e.g., “sandwiched”) between a plurality of members such as plates, at least one of the members being formed to define the walls of the reservoir or reservoirs where the reaction to be analyzed takes place. The reservoir walls are preferably an inert, opaque material such as a passivated metal (e.g., black anodized aluminum). Although the biosensor may include a gasket, the gasket is associated with the plurality of members and waveguide in such a way (e.g., by recessing the gasket into a channel formed into a metal plate) that the gasket does not form any significant portion of the reservoir wall. Waveguides of varying composition (e.g., plastic, quartz, glass or siliconoxynitride) may be associated with the members to form the biosensor. A lens or lenses may be integrated with the waveguide. The metal plate of the biosensor has input and output ports for infusing, draining, or oscillating the liquid to be analyzed in the reaction reservoir.
Due to the sandwiching of the waveguide in between the members, the planar waveguide is generally less distorted than that of an integrally formed biosensor. A reaction to be analyzed is not interfered with due to the use of opaque, inert metal to structurally define the reservoir.
The biosensor design is advantageously configured to interact with a flat waveguide having a rear integrated lens design for reading light passing through the waveguide (not fluorescent/evanescent light, but reading the core laser beam night) to monitor coupling efficiency and beam quality. The invention thus also includes a flat waveguide associated with a rear lens to couple light out of the waveguide (and a biosensor using such a lens) to serve as a quality control measure, thus insuring that the biosensor is properly placed and that the light source is working.
The invention also includes orienting the biosensor in a particular position relative to an optical reading device and laser which increases the performance of the biosensor to the point where, surprisingly, whole blood can be quickly analyzed.


REFERENCES:
patent: 5485277 (1996-01-01), Foster
patent: 5496701 (1996-03-01), Pollard-Knight
patent: 5677196 (1997-10-01), Herron et al.
patent: 5766956 (1998-06-01), Groger et al.
patent: 5832165 (1998-11-01), Reichert et al.
patent: 6023540 (2000-02-01), Walt et al.
patent: 6108463 (2000-08-01), Herron et al.
patent: 6316274 (2001-11-01), Herron et al.
patent: 6356676 (2002-03-01), Herron et al.
patent: 2027434 (1992-04-01), None
patent: 44 12893 (1995-10-01), None
patent: 0 185 126 (1986-06-01), None
patent: 0 478 137 (1992-01-01), None
patent: 0 517 516 (1992-12-01), None
patent: 0 519 623 (1992-12-01), None
patent: 0 700 514 (2002-02-01), None
patent: 2220083 (1989-12-01), None
patent: 943673 (1995-10-01), None
patent: WO 81/00912 (1981-04-01), None
patent: WO 88/10418 (1988-12-01), None
patent: WO 89/09408 (1989-10-01), None
patent: 9001166 (1990-02-01), None
patent: 9006503 (1990-06-01), None
patent: WO 91/01498 (1991-02-01), None
patent: WO 91/10122 (1991-07-01), None
patent: 9 113 339 (1991-09-01), None
patent: 9115751 (1991-10-01), None
patent: 9209892 (1992-06-01), None
patent: WO 92/16838 (1992-10-01), None
patent: WO 94/27137 (1994-11-01), None
patent: WO 95/03538 (1995-02-01), None
patent: WO 96/26432 (1996-08-01), None
patent: WO 96/32648 (1996-10-01), None
patent: WO 97/35176 (1997-09-01), None
patent: WO 97/35181 (1997-09-01), None
patent: WO 99/14594 (1999-03-01), None
patent: WO 99/36787 (1999-07-01), None
patent: WO 00/22408 (2000-04-01), None
Adams, III et al. “Comparable Detection of Acute Myocardial Infarction by Creatine Kinase MB Isoenzyme and Cardiac Troponin I,” Clinical Chemistry, 1994, pp. 1291-1295, vol. 40, No. 7.
Bakker et al., “The Mass Concentrations of Serum Troponin T and Creatine Kinase-MB are Elevated before Cretine Kinase and Cretine Kinase-MB Activities in Acute Myocardial Infarction,” Eur. J. Clin. Chem. Clin. Biochem., 1993, pp. 715-724, vol. 31, No. 11, Walter de Cruyter & Co., USA.
Bhayana et al., “Combination (Multiple) Testing for Myocardial Infarction Using Myoglobin, Creatine Kinase-2 (Mass), and Troponin T,” Clinical Biochemistry, 1994, pp. 395-406, vol. 27, No. 5, USA.
Caldwell, Li, Li and Dalgleish, “Adsorption behavior of milk proteins of polystrene Itex”,J. Chromatography 604: 63-71, Elsevier Science Publishers, 1992.
Carlsson, “Protein Thiolation and Reversible Protein-Protein Conjugation”,Biochem J., 173, pp. 723-737, 1978.
Choquette et al., “Planar Waveguide Immunosensor with Fluorescent Liposome Amplification,” American Chemical Society, 1991, pp. 55-60.
Ciana, Leopoldo Della, “Electrochemiluminescence Immunosensors And DNA Probes For Clinical Diagnostics”, Abstract, p. 19.
Cummins et al., “Comparison of serum cardiac specific troponin-I with creatine kinase, creatine kinase-MB isoenzyme, tropomyosin, myoglobin and C-reactive protein release in marathon runners: cardiac or skeletal muscle trauma?” European Journal of Clinical Investigation, 1987, pp. 317-324.
Discovery Technologies Ltd. Web Site, printed Dec. 27, 1999.
Discovery Technologies Ltd. Web Site, printed Jan. 3, 2000.
Fattinger et al., “The difference interferometer: a highly sensitive optical probe for quantification of molecular surface concentration,” Biosensors & Bioelectronics, 1993, pp. 99-107.
Fenton, J.J. et al., “Diagnostic Efficacy of a New Enzyme Immunoassay for Creatine Kinase MB Isoenzyme”, 30Clin. Chem., pp. 1399-1401 (1984).
Fitch, R., “Polymer Colloids: A Comprehensive Introduction”,Academic Press, Inc., 10 pages, 1997.
Gerhardt et al., “S-Troponin T in Suspected Ischemic Myocardial Injury Compared with Mass and Catalytic Concentrations of S-Creatine Kinase Isoenzyme MB,” 1991, pp. 1405-1411, vol. 37, No. 8.
Harmer, “Guilded-Wave Chemical

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Lens and associatable flow cell does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lens and associatable flow cell, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lens and associatable flow cell will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3079129

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.